HIGH

Wizcure Pharmaa Recalls Eye Drops Due to Sterility Concerns

Wizcure Pharmaa recalled 5,760 cartons of Vista Tears Eye Drops on December 31, 2025. The recall follows a lack of assurance of sterility in the product. Consumers should stop using the drops immediately and contact a healthcare provider for guidance.

Quick Facts at a Glance

Recall Date
December 31, 2025
Hazard Level
HIGH
Brand
Wizcure Pharmaa Private
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Wizcure Pharmaa Private Limited or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Vista Tears Eye Drops are intended for dry eye relief and lubrication. Consumers typically purchase these drops to alleviate discomfort caused by dryness or irritation in the eyes.

Why This Is Dangerous

The lack of assurance of sterility means that these eye drops may contain harmful bacteria or contaminants, posing a risk of eye infections upon use.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers are urged to stop using these eye drops immediately to avoid potential health risks. The financial impact will depend on whether consumers seek refunds or replacements.

Practical Guidance

How to identify if yours is affected

  1. Check the product label for the name 'Vista Tears' and the manufacturing details.
  2. Verify if your product is the 10 ml size with the NDC 77790-001-10.
  3. Look for any recalls listed on the FDA website.

Where to find product info

The NDC number and manufacturing details are usually found on the product packaging or label.

What timeline to expect

Expect a refund or replacement process to take approximately 4-6 weeks.

If the manufacturer is unresponsive

  • Document all communications with the retailer or manufacturer.
  • Consider reaching out to the FDA for guidance on further actions.

How to prevent similar issues

  • Look for eye drops with clear labeling of sterility assurance.
  • Consider purchasing from reputable brands with strong safety records.
  • Check for recent recalls before purchasing health products.

Documentation advice

Keep records of your purchase, including receipts and any correspondence related to the recall.

Product Details

The recalled product is Vista Tears Polyethylene Glycol 400 0.4% w/v and Propylene Glycol 0.3% w/v Eye Drops. The product is packaged in 10 ml (1/3 fl. oz.) bottles. It was manufactured by Omni Lens Pvt. Ltd. and distributed by hi-health.

Key Facts

  • 5,760 cartons recalled nationwide
  • Lack of sterility assurance
  • Distributed by hi-health in Scottsdale, AZ
  • Contact healthcare provider for guidance

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
All lots
Affected States
ALL
Report Date
March 4, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more